SBIR/STTR Research Award

Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries

Award identifier 3570e44b73b7b1ec0d2bf6e6780093917b871c7abe468db96c3aef1706bd6981Awarding agency Department of Defense · Army

Award amount

$780,029

Program and phase

SBIR · Phase II

Award year

2012

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
Zeomedix
Proposal award date
2011-12-29
Contract end date
2014-09-30
UEI
Not reported
Solicitation number
2010.3
Topic code
A10-160

Research abstract

In this proposal Zeomedix proposes to develop a dressing for infected trauma wounds based on its zeolite encapsulating nitric oxide (NO) technology. Nitric oxide has been shown to enhance the wound healing process as well as act as a powerful antibacterial agent. However, delivery of nitric oxide to a wound area is extremely challenging because NO is a gas. Zeomedixs approach is to use zeolites that bind NO molecules when exposed to a stream of gaseous NO. When NO-loaded zeolites come in contact with water (or wound fluid), NO is released into the wound area. The overall goal of Zeomedixs Phase II project is to develop an optimal NO-zeolite wound dressing for treating infected acute wounds. Our technical approach can be organized into three steps: (1) Develop three different NO-zeolite wound dressing prototypes, consisting of NO-zeolite ointment enclosed within a semi-porous pouch, each having distinct nitric oxide release rates. (2) Characterize the storage stability, cytotoxicity, and antimicrobial efficacy of the prototypes against both planktonic microorganisms and bacterial biofilms in vitro. (3) Evaluate the ability of the two leading prototypes to reduce wound infection and improve wound healing in vivo using a full-thickness infected porcine wound model. The overall goal of Zeomedixf"ff3/4s Phase II project is to develop an optimal NO-zeolite wound dressing for treating infected acute wounds. Our technical approach can be organized into three steps: (1) Develop three different NO-zeolite wound dressing prototypes, consisting of NO-zeolite ointment enclosed within a semi-porous pouch, each having distinct nitric oxide release rates (2) Characterize the storage stability, cytotoxicity, and antimicrobial efficacy of the prototypes against both planktonic microorganisms and bacterial biofilms in vitro (3) Evaluate the ability of the two leading prototypes to reduce wound infection and improve wound healing in vivo using a full-thickness infected porcine wound model

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.